Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: A review

SS Santos, RV de Araujo, J Giarolla, O El Seoud… - International journal of …, 2020 - Elsevier
Chagas disease, leishmaniasis and schistosomiasis are neglected diseases (NDs) and are
a considerable global challenge. Despite the huge number of people infected, NDs do not …

Current advances in drug discovery for Chagas disease

CB Scarim, DH Jornada, RC Chelucci… - European journal of …, 2018 - Elsevier
Chagas disease, also known as American trypanosomiasis, is one of the 17 neglected
tropical diseases (NTDs) according to World Health Organization. It is estimated that 8–10 …

Nitro-group-containing drugs

K Nepali, HY Lee, JP Liou - Journal of medicinal chemistry, 2018 - ACS Publications
The nitro group is considered to be a versatile and unique functional group in medicinal
chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues …

Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites

JJ Nué-Martinez, D Cisneros… - Journal of Medicinal …, 2023 - ACS Publications
The AT-rich mitochondrial DNA (kDNA) of trypanosomatid parasites is a target of DNA minor
groove binders. We report the synthesis, antiprotozoal screening, and SAR studies of three …

Current and future prospects of nitro-compounds as drugs for trypanosomiasis and leishmaniasis

S Patterson, AH Fairlamb - Current medicinal chemistry, 2019 - benthamdirect.com
Interest in nitroheterocyclic drugs for the treatment of infectious diseases has undergone a
resurgence in recent years. Here we review the current status of monocyclic and bicyclic …

Nitro compounds against trypanosomatidae parasites: Heroes or villains?

PF da Silva Santos-Júnior, LR Silva… - Bioorganic & Medicinal …, 2022 - Elsevier
Abstract Chagas disease and Human African trypanosomiasis (HAT) are caused by
Trypanosoma cruzi, T. brucei rhodesiense or T. b. gambiense parasites, respectively; while …

Thio- and selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis

A Ibáñez-Escribano, C Fonseca-Berzal… - Journal of enzyme …, 2022 - Taylor & Francis
Herein, we report the preparation of a panel of Schiff bases analogues as antiprotozoal
agents by modification of the stereoelectronic effects of the substituents on N-1 and N-4 and …

Dearomative spiroannulation of indoles enabled by the diaza-[1, 2]-Wittig rearrangement

C Luo, CY Guan, ZY Li, B Gao, GJ Mei - Organic Chemistry Frontiers, 2024 - pubs.rsc.org
The first diaza-[1, 2]-Wittig rearrangement-enabled dearomative spiroannulation (DSA)
reaction of indoles is reported. In contrast to the previous dearomatization approaches using …

[HTML][HTML] Novel Treatment Approaches to Combat Trichomoniasis, a Neglected and Sexually Transmitted Infection Caused by Trichomonas vaginalis: Translational …

GV Rigo, LA Frank, GB Galego, ALS Santos, T Tasca - Venereology, 2022 - mdpi.com
The multistep translational science behind new drugs comprehends the entire process
through laboratory, clinical, and community observations turned into health interventions …

Recent developments in anti-Trichomonas research: An update review

V Bala, YS Chhonker - European Journal of Medicinal Chemistry, 2018 - Elsevier
Trichomonas vaginalis is a major non-viral sexually-transmitted infection resulted into
serious obstetrical and gynecological troubles. The increasing resistance to nitroimidazole …